Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

Lederle (Japan) reports novel cardioprotective agents

April 10, 1997

SmithKline Beecham claims novel endothelin antagonists

April 9, 1997

AMBI's Cardia Salt Alternative associated with reduced blood pressure

April 9, 1997

Component of olive oil demonstrates antioxidant and lipoxygenase-inhibitory effects

April 8, 1997

Transmyocardial Revascularization phase II results reported

April 7, 1997

Yamanouchi characterizes new vasopressin antagonist, YM-087

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Perindopril accelerates endothelial regrowth in animal model

April 7, 1997

Targeted Genetics' AAV vector useful for in vivo cardiovascular gene therapy

April 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...